References
- Perez-Soler R., Lopez-Berestein G., Lautersztain J., Al-Baker S., Francis K., Macias-Kiger D., Raber M.N., Khokhar A.R. Phase I clinical and pharmacologic study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diam-inocyclohexane platinum (II). Cancer Res. 1990; 50: 4254–4259
- Sculier J.-P., Coune A., Meunier F., Brassinne C., Laduron C., Hollaert C., Collette N., Heymans C., Klastersky J. Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. Eur. J. Cancer Clin. Oncol. 1988; 24(3)527–538
- Gabizon A., Shiota R., Papahadjopoulos D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposome with long circulation times. J. Natl. Cancer Inst. 1989; 81(19)1484–1488
- Graybill J.R., Craven P.C., Taylor R.L., Williams D.M., Magee W.E. Treatment of murine cryptococcosis with liposome associated amphotericin B. J. Infect. Dis. 1982; 145: 740–752
- Ahrens J., Graybill J.R., Craven P.C., Taylor R.L. Treatment of experiment murine candidiasis will liposome associated amphotericin B Sabouraudia. J. Med. Vet. Mycol. 1984; 22: 163–166
- Tremblay C., Barza M., Fiore C., Szoka F. Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob. Agents Chemother. 1984; 26(2)170–173
- Berman J.D., Hanson W.L., Chapman W.L., Alving C.R., Lopez-Berestein G. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob. Agents. Chemother. 1986; 30(6)847–851
- Panosian C.B., Barza M., Szoka F., Wyler D.J. Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B. Antimicrob. Agents Chemother. 1984; 25(5)655–656
- Lopez-Berestein G., Bodey G.P., Fainstein V., Keating M., Frankel L.S., Zeluff B., Gentry L., Mehta K. Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med. 1989; 149: 2533–2536